Obesity-hypoventilation SyndromeNCT04474587
Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV
An observational study of Obesity-hypoventilation Syndrome and Resting Energy Expenditure, run by University Hospital, Geneva at 1 site in Switzerland.
Trial summary
This study aims to compare, in subjects with obesity-hypoventilation syndrome (OHS) treated by long-term non-invasive ventilation (NIV), resting energy expenditure (REE) in spontaneous breathing and under NIV. The hypothesise of this study is that REE will be lower under NIV than under spontaneous breathing. Read more about this study
- Who is it for?
- Ages 18 to 100 years
- Conditions the study is for
- Obesity-hypoventilation Syndrome, Resting Energy Expenditure, Long-term Non-invasive Ventilation
- What is being tested?
- Indirect calorimetry
- How many people
- 30 participants
- Where
- 1 siteSwitzerland
- Study dates
- 1 Sep 2020to 1 Dec 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- Adult, Older adult
Study population: Patients with obesity hypoventilation syndrome (OHS) trated with non-invasive ventilation (NIV).
Who may be able to join
- Fulfill all criteria of obesity hypoventilation syndrome.
- Under home NIV for at least 3 months.
- Are compliant to their treatment of NIV (defined as a daily median use > 3:30 hours).
- Have a satisfactory response to NIV (defined by a daytime PaCO2 in a sitting position < 6.5 kPa, and a mean nocturnal SpO2 > 90%, with less than 20% of total recording time spent with an SpO2 < 90%).
- Are in a stable clinical condition (i.e. no episode of acute cardiac and/or respiratory failure leading to a hospitalization within the preceding 3 months).
- Are over 18 years of age.
- Are able to provide informed consent.
- Agree to participate in the study.
Who cannot join
- Presents any respiratory disorder other than OHS.
- Has been under NIV less than 3 months.
- Is noncompliant (defined above) and/or intolerant to NIV.
- NIV not reaching the above-mentioned physiological targets (defined by a daytime PaCO2 in a sitting position < 6.5 kPa, and a mean nocturnal SpO2 > 90%, with less than 20% of total recording time spent with an SpO2 < 90%).
- Had a recent episode of cardiac and/or respiratory failure leading to a hospitalization within the preceding 3 months.
- Is under 18 years of age.
Show all 9Show fewer
- Presents a situation interfering with understanding of the protocol and ability to provide informed written consent (language barrier, cognitive disorder, psychiatric disturbance).
- Refuses to participate in the study.
- Is under nocturnal oxygen supplementation on NIV.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Impact of Noninvasive Ventilation on Resting Energy Expenditure in Patients With Obesity Hypoventilation Syndrome Treated by Long-term Home Noninvasive Ventilation.
This study aims to compare, in subjects with obesity-hypoventilation syndrome (OHS) treated by long-term non-invasive ventilation (NIV), resting energy expenditure (REE) in spontaneous breathing and under NIV. The hypothesise of this study is that REE will be lower under NIV than under spontaneous breathing.
Read the detailed description
This is an observational monocentric study in which each subject will be its own control. Patients' resting energy expenditure will be measured at rest ("spontaneous breathing" condition) and under its usual treatment ("under NIV" condition) in a cross-over fashion. Conditions measurement order will be randomly generated by a computer algorithm such that half of the patients will be measured under spontaneous breathing before under NIV and the other half of the patients will be measured under NIV before under spontaneous breathing. Resting energy expenditure will be monitored during a short-term elective hospitalization (24 hours). Albeit for measurements of REE, tests which will be performed are part of the regular follow-up of patients under long term NIV.
Primary objective is to compare in OHS patients the REE under spontaneous breathing and under NIV, using their usual settings.
Description of the intended procedures and stages:
- Recruitment and screening of patients fulfilling inclusion criteria will be done among patients with OHS under long-term NIV followed by our center (duration: 14 days).
- Once informed written consent has been provided, patients will be included in the study protocol (time provided for decision: 28 days).
- Patients are admitted for one night with overnight recording of nocturnal oximetry and transcutaneous capnography using their noninvasive ventilation at usual settings, prior to measurements of resting energy expenditure. Downloading of memorized data by ventilator software will also take place and will cover the previous month and the night of the study (duration: 12 hours). These procedures are part of the routine evaluation of patients under long term NIV.
- Body weight will be measured, as well as body composition by bioelectrical impedance: briefly, a very low intensity electric current is sent between 2 electrodes placed on the dorsum of the foot and the ipsilateral hand. Measurement of resistance and reactance allows estimation of body compartments (fat-free mass and fat mass) (duration: 30 minutes).
- Patients will undergo their first indirect calorimetric measurement. Prior to REE measurements, patients must be fasting for at least 10 hours, in a supine position, or if required for patient comfort, with a 30° inclination of head rest for at least 30 minutes. REE measurements are either performed with or without noninvasive ventilation (conditions order will be randomized by a computer)(duration: 30 minutes of rest and 20-30 minutes of indirect calorimetry).
- Interval between measurements of at least 1 hour, to avoid impact of noninvasive ventilation on measurements. Between tests, they will perform pulmonary function tests and have their arterialized capillary blood gases sampled at earlobe (duration: 1 hour). These tests are part of the routine evaluation of patients under long term NIV.
- Patients will undergo their second indirect calorimetric measurement (see details in section on indirect calorimetric). Prior to REE measurements, patients must be fasting for at least 10 hours, in a supine position, or if required for patient comfort, with a 30° inclination of head rest for at least 30 minutes. REE measurements are either done with or without noninvasive ventilation (randomized order by a software) (duration: 30 minutes of rest and 20-30 minutes of indirect calorimetry).
- These two tests will be performed in a randomized order (spontaneous breathing or noninvasive ventilation).
- Information to the patient of the results, which will also be forwarded to physician and nutritionist in charge.
In 2016-2017, seventy-four OHS patients treated at home by long-term NIV were identified in our area. Expecting a participation rate of around 50%, at least 30 patients will be included in the present study. With such a sample size, the study will have a power of 80% to detect an effect size of 0.5.
- Conditions
- Obesity-hypoventilation Syndrome, Resting Energy Expenditure, Long-term Non-invasive Ventilation
- Being tested
- Indirect calorimetry
- Medical subject headings
- Obesity Hypoventilation Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Indirect calorimetryOther
Measurements of REE by indirect calorimetry
| Study group | Role | What they receive |
|---|---|---|
| OHS-NIV | Patients with obesity-hypoventilation syndrome (OHS) treated with non-invasive ventilation (NIV). Receives: Other: Indirect calorimetry |
What is being measured
The primary outcome is the main question the study is designed to answer.
REE
Resting energy expenditure (REE) and will be determined under spontaneous breathing and under NIV with an indirect calorimetry
Measured: Each procedure (indirect calorimetry) will take 30 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2020
- Study start1 Sep 2020
- Primary completion1 Dec 2022 (estimated)
- Study completion1 Dec 2022 (estimated)
Why it stopped: COVID pandemic
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Obesity-hypoventilation SyndromeStudies of the same condition, open and under way.
- More trials run by University Hospital, GenevaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Geneva
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jean-Paul Janssens, University Hospital, Geneva
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04474587
- Sponsor's protocol ID
- 2020-01223
- Status last verified
- Oct 2021
- First submitted
- 13 Jul 2020
- Last updated
- 8 Nov 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Nov 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Noninvasive Ventilation on Resting Energy Expenditure in Patients With Obesity Hypoventilation Syndrome Treated by Long-term Home Noninvasive Ventilation.
- ClinicalTrials.gov ID
- NCT04474587
- Acronym / sponsor ID
- 2020-01223
- Conditions
- Obesity-hypoventilation Syndrome, Resting Energy Expenditure, Long-term Non-invasive Ventilation
- Study type
- Observational
- Recruitment status
- SuspendedReason stopped: COVID pandemic
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- University Hospital, GenevaUniversity, hospital or other
- Study start
- 1 Sep 2020 (actual)
- Primary completion
- 1 Dec 2022 (estimated)
- Study completion
- 1 Dec 2022 (estimated)
- First posted
- 17 Jul 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to compare, in subjects with obesity-hypoventilation syndrome (OHS) treated by long-term non-invasive ventilation (NIV), resting energy expenditure (REE) in spontaneous breathing and under NIV. The hypothesise of this study is that REE will be lower under NIV than under spontaneous breathing.
Detailed description
This is an observational monocentric study in which each subject will be its own control. Patients' resting energy expenditure will be measured at rest ("spontaneous breathing" condition) and under its usual treatment ("under NIV" condition) in a cross-over fashion. Conditions measurement order will be randomly generated by a computer algorithm such that half of the patients will be measured under spontaneous breathing before under NIV and the other half of the patients will be measured under NIV before under spontaneous breathing. Resting energy expenditure will be monitored during a short-term elective hospitalization (24 hours). Albeit for measurements of REE, tests which will be performed are part of the regular follow-up of patients under long term NIV.
Primary objective is to compare in OHS patients the REE under spontaneous breathing and under NIV, using their usual settings.
Description of the intended procedures and stages:
- Recruitment and screening of patients fulfilling inclusion criteria will be done among patients with OHS under long-term NIV followed by our center (duration: 14 days).
- Once informed written consent has been provided, patients will be included in the study protocol (time provided for decision: 28 days).
- Patients are admitted for one night with overnight recording of nocturnal oximetry and transcutaneous capnography using their noninvasive ventilation at usual settings, prior to measurements of resting energy expenditure. Downloading of memorized data by ventilator software will also take place and will cover the previous month and the night of the study (duration: 12 hours). These procedures are part of the routine evaluation of patients under long term NIV.
- Body weight will be measured, as well as body composition by bioelectrical impedance: briefly, a very low intensity electric current is sent between 2 electrodes placed on the dorsum of the foot and the ipsilateral hand. Measurement of resistance and reactance allows estimation of body compartments (fat-free mass and fat mass) (duration: 30 minutes).
- Patients will undergo their first indirect calorimetric measurement. Prior to REE measurements, patients must be fasting for at least 10 hours, in a supine position, or if required for patient comfort, with a 30° inclination of head rest for at least 30 minutes. REE measurements are either performed with or without noninvasive ventilation (conditions order will be randomized by a computer)(duration: 30 minutes of rest and 20-30 minutes of indirect calorimetry).
- Interval between measurements of at least 1 hour, to avoid impact of noninvasive ventilation on measurements. Between tests, they will perform pulmonary function tests and have their arterialized capillary blood gases sampled at earlobe (duration: 1 hour). These tests are part of the routine evaluation of patients under long term NIV.
- Patients will undergo their second indirect calorimetric measurement (see details in section on indirect calorimetric). Prior to REE measurements, patients must be fasting for at least 10 hours, in a supine position, or if required for patient comfort, with a 30° inclination of head rest for at least 30 minutes. REE measurements are either done with or without noninvasive ventilation (randomized order by a software) (duration: 30 minutes of rest and 20-30 minutes of indirect calorimetry).
- These two tests will be performed in a randomized order (spontaneous breathing or noninvasive ventilation).
- Information to the patient of the results, which will also be forwarded to physician and nutritionist in charge.
In 2016-2017, seventy-four OHS patients treated at home by long-term NIV were identified in our area. Expecting a participation rate of around 50%, at least 30 patients will be included in the present study. With such a sample size, the study will have a power of 80% to detect an effect size of 0.5.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| OHS-NIV | – | Other: Indirect calorimetryPatients with obesity-hypoventilation syndrome (OHS) treated with non-invasive ventilation (NIV). |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Patients with obesity hypoventilation syndrome (OHS) trated with non-invasive ventilation (NIV).
Key inclusion criteria (8 listed)
- Fulfill all criteria of obesity hypoventilation syndrome.
- Under home NIV for at least 3 months.
- Are compliant to their treatment of NIV (defined as a daily median use > 3:30 hours).
- Have a satisfactory response to NIV (defined by a daytime PaCO2 in a sitting position < 6.5 kPa, and a mean nocturnal SpO2 > 90%, with less than 20% of total recording time spent with an SpO2 < 90%).
- Are in a stable clinical condition (i.e. no episode of acute cardiac and/or respiratory failure leading to a hospitalization within the preceding 3 months).
Key exclusion criteria (9 listed)
- Presents any respiratory disorder other than OHS.
- Has been under NIV less than 3 months.
- Is noncompliant (defined above) and/or intolerant to NIV.
- NIV not reaching the above-mentioned physiological targets (defined by a daytime PaCO2 in a sitting position < 6.5 kPa, and a mean nocturnal SpO2 > 90%, with less than 20% of total recording time spent with an SpO2 < 90%).
- Had a recent episode of cardiac and/or respiratory failure leading to a hospitalization within the preceding 3 months.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Indirect calorimetryMeasurements of REE by indirect calorimetry | Other | OHS-NIV |
Primary outcome
REE
Time frame: Each procedure (indirect calorimetry) will take 30 minutes
Resting energy expenditure (REE) and will be determined under spontaneous breathing and under NIV with an indirect calorimetry
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Nov 2021.
Related trials for Obesity-hypoventilation Syndrome
Not yet recruitingPhase 2
Oxytocin for Respiratory Compromise and Hypoventilation Induced by Drugs
Obesity & Overweight, Respiratory Depression
Not yet recruiting
Hypercapnic Burden in Adults With Obesity Undergoing Diagnostic Polysomnography for Suspected Obstructive Sleep Apnea
Obstructive Sleep Apnea, Obesity (BMI>30)
Active, not recruitingObservational study
Early Check: Expanded Screening in Newborns
Spinal Muscular Atrophy, Fragile X Syndrome
RecruitingObservational study
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
Childhood Obesity, Morbid Obesity
Not yet recruiting
Prevalence of Nocturnal Hypoventilation in Obese Subjects Fiited With Continuous Positive Airway Pressure for Obstructive Sleep Apnea / Hypopnea Syndrome
Nocturnal Hypoventilation, Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Obesity-hypoventilation Syndrome and Resting Energy Expenditure, run by University Hospital, Geneva at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: paused, as of the sponsor's last update on 8 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
REE (time frame: Each procedure (indirect calorimetry) will take 30 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2021.